Search for Clinical Trial Results
Acute Myeloblastic Leukemia Without Maturation - 182 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition:
|
Active, not recruiting |
Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condition:
|
Withdrawn |
Study Name: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition:
|
Completed |
Study Name: Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy Condition:
|
Completed |
Study Name: Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia Condition:
|